journal article·2022-11-01

Facile construction of tumour spheroids with induced M2 macrophage polarization for anticancer drug screening

Na Ly Tran, In Kyu Lee, Hyerim Kim, Kangwon Lee, Sang-Heon Kim, Seung Ja Oh

Biomedical Materials· Volume 17· Issue 6
Publisher page

Abstract

Abstract Tumour-associated macrophages (TAMs) are involved in cancer progression and drug resistance in the tumour microenvironment (TME). Consequently, macrophages as therapeutic targets have garnered increased attention; however, there are hurdles to screening interactions between cancer and macrophages owing to technical difficulties in recapitulating in vitro physiological systems. In this study, we propose a simple strategy to construct tumour spheroids with induced M2 macrophage polarization for anticancer drug screening. We observed that cytokine expression related to the TME in three-dimensional (3D) cancer spheroids was enhanced compared with that in two-dimensional conventional cancer cell cultures. We also demonstrated that the 3D breast tumour spheroids promote M2-like TAM polarization via granulocyte–macrophage colony-stimulating factor and granulocyte colony-stimulating factor. Furthermore, adipose tissue-derived stem cells, an abundant stromal cell population in the breast cancer TME, further enhanced the M2 phenotype in the in vitro tumour spheroids. Therefore, we propose the tumour spheroids as a drug screening platform to evaluate drug efficacy in cancers. Overall, the simple strategy to form tumour spheroids developed in this study will broaden the understanding of communication between cancer cells and macrophages and contribute to the evaluation of cancers and the development of better strategies for their therapy and management.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Immune cells in cancer · Cancer Cells and Metastasis · Epigenetics and DNA Methylation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (48)

Show source-provided references
1. Tumor promoting role of anti-tumor macrophages in tumor microenvironment10.1016/j.cellimm.2017.04.005 ↗
2. Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications10.1186/s13045-019-0760-3 ↗
3. Role of tumor-associated macrophages in human malignancies: friend or foe?10.1111/pin.12440 ↗
4. Tumor-associated macrophages in breast cancer: innocent bystander or important player?10.1016/j.ctrv.2018.08.010 ↗
5. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries10.3322/caac.21492 ↗
6. Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors10.1089/adt.2014.573 ↗
7. 2D and 3D cell cultures—a comparison of different types of cancer cell cultures10.5114/aoms.2016.63743 ↗
8. 3D cell coculture tumor model: a promising approach for future cancer drug discovery10.1016/j.procbio.2018.12.028 ↗
9. 3D cell culture systems: advantages and applications10.1002/jcp.24683 ↗
10. Mimicking the tumor microenvironment to regulate macrophage phenotype and assessing chemotherapeutic efficacy in embedded cancer cell/macrophage spheroid models10.1016/j.actbio.2016.12.037 ↗
11. Interleukin 6 induces M2 macrophage differentiation by STAT3 activation that correlates with gastric cancer progression10.1007/s00262-017-2052-5 ↗
12. IL-6 influences the polarization of macrophages and the formation and growth of colorectal tumor10.18632/oncotarget.24734 ↗
13. Beswick, G-CSF and G-CSFR induce a pro-tumorigenic macrophage phenotype to promote colon and pancreas tumor growth10.3390/cancers12102868 ↗
14. Tumour-associated macrophages as treatment targets in oncology10.1038/nrclinonc.2016.217 ↗
15. Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells10.1073/pnas.1106645108 ↗
16. Functional relationship between tumor-associated macrophages and macrophage colony-stimulating factor as contributors to cancer progression10.3389/fimmu.2014.00489 ↗
17. An optimized protocol for human M2 macrophages using M-CSF and IL-4/IL-10/TGF-β yields a dominant immunosuppressive phenotype10.1111/sji.12162 ↗
18. The role of tumor-stroma interactions in drug resistance within tumor microenvironment10.3389/fcell.2021.637675 ↗
19. Recruitment of stromal cells into tumour microenvironment promote the metastatic spread of breast cancer10.1016/j.semcancer.2019.07.028 ↗
20. Expression profile of IL-8 and growth factors in breast cancer cells and adipose-derived stem cells (ASCs) isolated from breast carcinoma10.1016/j.cellimm.2010.07.006 ↗
21. Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses10.1158/0008-5472.CAN-12-2731 ↗
22. Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial10.1016/S1470-2045(16)00078-4 ↗
23. Targeting the tumour stroma to improve cancer therapy10.1038/s41571-018-0007-1 ↗
24. In vitro 3D cultures to model the tumor microenvironment10.3390/cancers13122970 ↗
25. Tumor-induced inflammatory cytokines and the emerging diagnostic devices for cancer detection and prognosis10.3389/fonc.2021.692142 ↗
26. 3D modeling of cancer stem cell niche10.18632/oncotarget.19847 ↗
27. Cancer-associated adipocyte-derived G-CSF promotes breast cancer malignancy via Stat3 signaling10.1093/jmcb/mjaa016 ↗
28. G-CSF regulates macrophage phenotype and associates with poor overall survival in human triple-negative breast cancer10.1080/2162402X.2015.1115177 ↗
29. Breast cancer-derived GM-CSF regulates arginase 1 in myeloid cells to promote an immunosuppressive microenvironment10.1172/JCI145296 ↗
30. Macrophages may promote cancer growth via a GM-CSF/HB-EGF paracrine loop that is enhanced by CXCL1210.1186/1476-4598-9-273 ↗
31. Distinctive effects of GM-CSF and M-CSF on proliferation and polarization of two major pulmonary macrophage populations10.4049/jimmunol.1801387 ↗
32. Defining GM-CSF- and macrophage-CSF dependent macrophage responses by in vitro models10.4049/jimmunol.1103426 ↗
33. The extracellular matrix: a dynamic niche in cancer progression10.1083/jcb.201102147 ↗
34. Hyaluronic acid-based extracellular matrix triggers spontaneous M2-like polarity of monocyte/macrophage10.1039/C9BM00155G ↗
35. Biomechanical contributions to macrophage activation in the tumor microenvironment10.3389/fonc.2020.00787 ↗
36. Obesity promotes breast cancer by CCL2-mediated macrophage recruitment and angiogenesis10.1158/0008-5472.CAN-13-0926 ↗
37. Adipose tissue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activation10.1152/ajpendo.00329.2010 ↗
38. Dendritic cell-specific ICAM-3-grabbing nonintegrin expression on M2-polarized and tumor-associated macrophages is macrophage-CSF dependent and enhanced by tumor-derived IL-6 and IL-1010.4049/jimmunol.1000475 ↗
39. Comparison of 2D-and 3D-culture models as drug-testing platforms in breast cancer10.1158/1538-7445.AM2015-319 ↗
40. Drug resistance evaluation in novel 3D in vitro model10.1016/j.biopha.2021.111536 ↗
41. 3D-3-culture: a tool to unveil macrophage plasticity in the tumour microenvironment10.1016/j.biomaterials.2018.02.030 ↗
42. Monocyte differentiation towards protumor activity does not correlate with M1 or M2 phenotypes10.1155/2016/6031486 ↗
43. Dynamic gene regulatory networks of human myeloid differentiation10.1016/j.cels.2017.03.005 ↗
44. Generation and functional characterization of monocytes and macrophages derived from human induced pluripotent stem cells10.1002/cpsc.108 ↗
45. Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancer10.1038/s41523-019-0130-x ↗
46. The role of the extracellular matrix and its molecular and cellular regulators in cancer cell plasticity10.3389/fonc.2018.00431 ↗
47. Extracellular matrix and its therapeutic potential for cancer treatment10.1038/s41392-021-00544-0 ↗
48. Macrophage differentiation and polarization into an M2-Like phenotype using a human monocyte-like THP-1 leukemia cell line10.3791/62652 ↗